Dr. G K Jadhav

Dr. G K Jadhav is a Senior Consultant and Clinical Advisor in Radiation Oncology at Indraprastha Apollo Hospital in New Delhi, widely recognized as one of India's leading radiation oncologists. With over 35 years of clinical practice, he brings exceptional depth to the field of precision cancer radiotherapy, combining decades of experience with mastery of the most advanced treatment technologies available today.

Dr. Jadhav's clinical expertise spans the full spectrum of oncological radiation therapy. He is highly skilled in stereotactic radiosurgery (SRS) for both benign and malignant brain tumors, stereotactic body radiation therapy (SBRT) for complex cases involving the prostate, spine, lung, and liver, and image-guided radiation therapy with adaptive techniques. His particular proficiency lies in fractionated and hypo-fractionated radiation protocols for breast and prostate cancers, as well as management of recurrent tumors and head and neck malignancies. He has served as Principal Investigator for multiple global clinical trials in neuro-oncology, staying at the forefront of emerging methodologies.

Dr. Jadhav has built a substantial international patient practice, treating patients from across the Gulf region, Africa, and SAARC countries. He is fluent in English and Hindi, and has developed a reputation for taking time to explain complex treatment plans in accessible language, making him particularly valued by patients seeking a second opinion or comprehensive cancer care abroad. His approach emphasizes personalized treatment planning and long-term quality of life outcomes.

Indraprastha Apollo Hospital, where Dr. Jadhav practices, is one of India's flagship tertiary care centers, equipped with state-of-the-art linear accelerators, planning systems, and imaging infrastructure. The hospital maintains international accreditation and serves as a hub for cancer care in South Asia, with dedicated support for international patients including visa assistance and accommodation coordination. For patients traveling from the Middle East, Africa, or Central Asia, Apollo's established protocols and multilingual teams ensure seamless care continuity.

International patients choosing Dr. Jadhav benefit from world-class radiation oncology delivered at a fraction of costs found in Western nations, combined with his extensive track record of managing complex, internationally referred cases. His involvement in global trials and memberships in organizations such as AROI, ICRO, and UICC reflect his commitment to maintaining the highest standards of evidence-based practice.